Trinity Biotech | TRIB - Cost Of Sales


Trinity Biotech reported $7.17M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Bio-Rad Laboratories USD 348M 38.4M Dec/2025
EDAP TMS EUR 7.91M 1.31M Sep/2025
J&J USD 8.07B 103M Mar/2026
Mesa Laboratories USD 21.92M 1.78M Sep/2024
OraSure Technologies USD 15.43M 113K Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Siemens EUR 12.07B 565M Mar/2026
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Tosoh JPY 193.73B 3.46B Mar/2026
Trinity Biotech USD 7.17M 666K Dec/2025
Veracyte USD 38.49M 794K Mar/2026